Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
260 rows where has_known_aptamer = 1, surface_class = "B_cargo" and tier = "Tier 1.5" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total
tier 1
- Tier 1.5 · 260 ✖
surface_class 1
- B_cargo · 260 ✖
has_known_aptamer 1
- 1 · 260 ✖
has_activation_state_pdb_pair 1
- 0 260
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P14136 | GFAP | Glial fibrillary acidic protein | Tier 1.5 | 0.761 | 1 | B_cargo | 1 | 80.0 | 0 | 0 | 1 | 4 | 42022738, 40983220, 27924617, 27399849 | 1 | Alexander disease | 0.8713727112153956 | ||
| P00480 | OTC | Ornithine transcarbamylase, mitochondrial | Tier 1.5 | 0.76 | 1 | B_cargo | 4 | 92.19 | 0 | 0 | 1 | 71 | 42031033, 41819402, 41207276, 41033028, 40970979, 40801924, 40719766, 40644866, 40602786, 40187287, 40064103, 40015047, 39904249, 39644528, 39571486, 39275399, 39030014, 38504447, 38193253, 37459789, 37364386, 37103619, 36891736, 36618689, 36454704, 36403375, 35884270, 35672499, 35006795, 34973550, 34821674, 34684942, 34152736, 33812186, 33035887, 32862845, 32768827, 32674777, 31673790, 31580049, 31325751, 31016392, 30837641, 30778448, 30594079, 30426224, 30202432, 30128033, 29937498, 28578167 | 1 | ornithine carbamoyltransferase deficiency | 0.8675763935672858 | ||
| P11532 | DMD | Dystrophin | Tier 1.5 | 0.76 | 1 | B_cargo | 6 | 76.38 | 0 | 0 | 1 | 32 | 41983899, 41503480, 41083485, 40396427, 39910928, 39469668, 38050701, 37765072, 37261868, 34876524, 34693888, 34440571, 34075115, 33617542, 32592467, 28315675, 28252048, 27530235, 27173731, 26594036, 26163061, 26039989, 21838691, 20962041, 17011811, 38448545 | 1 | Duchenne muscular dystrophy | 0.865885140119287 | ||
| P05165 | PCCA | Propionyl-CoA carboxylase alpha chain, mitochondrial | Tier 1.5 | 0.756 | 1 | B_cargo | 25 | 87.44 | 1 | 0 | 1 | 1 | 36578103 | 1 | propionic acidemia | 0.8530542602972598 | ||
| P35475 | IDUA | Alpha-L-iduronidase | Tier 1.5 | 0.755 | 1 | B_cargo | 11 | 94.75 | 0 | 0 | 1 | 1 | 18838694 | 1 | Scheie syndrome | 0.8500187612858606 | ||
| P26440 | IVD | Isovaleryl-CoA dehydrogenase, mitochondrial | Tier 1.5 | 0.754 | 1 | B_cargo | 5 | 93.38 | 1 | 0 | 1 | 2 | 41230502, 26946282 | 1 | isovaleric acidemia | 0.8480603595890895 | ||
| P48637 | GSS | Glutathione synthetase | Tier 1.5 | 0.754 | 1 | B_cargo | 2 | 94.94 | 0 | 0 | 1 | 1 | 24296062 | 1 | Glutathione synthetase deficiency | 0.8480115629745476 | ||
| P50897 | PPT1 | Palmitoyl-protein thioesterase 1 | Tier 1.5 | 0.752 | 1 | B_cargo | 1 | 91.69 | 0 | 0 | 1 | 2 | 33112630 | 1 | neuronal ceroid lipofuscinosis 1 | 0.8400332147230634 | ||
| P50416 | CPT1A | Carnitine O-palmitoyltransferase 1, liver isoform | Tier 1.5 | 0.751 | 1 | B_cargo | 1 | 92.44 | 0 | 0 | 1 | 1 | 29325019 | 1 | carnitine palmitoyl transferase 1A deficiency | 0.8360102017303558 | ||
| P48728 | AMT | Aminomethyltransferase, mitochondrial | Tier 1.5 | 0.749 | 1 | B_cargo | 2 | 93.69 | 0 | 0 | 1 | 6 | 41360349, 38751431, 36935143, 32969502, 32779681, 32062632 | 1 | glycine encephalopathy | 0.8307194416875259 | ||
| P55157 | MTTP | Microsomal triglyceride transfer protein large subunit | Tier 1.5 | 0.748 | 1 | B_cargo | 2 | 86.56 | 1 | 0 | 1 | 1 | 23770039 | 1 | abetalipoproteinemia | 0.8281089516017405 | ||
| Q53H12 | AGK | Acylglycerol kinase, mitochondrial | Tier 1.5 | 0.747 | 1 | B_cargo | 1 | 87.0 | 1 | 0 | 1 | 1 | 35763566 | 1 | Sengers syndrome | 0.8231275438888749 | ||
| P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | Tier 1.5 | 0.744 | 1 | B_cargo | 10 | 87.25 | 1 | 0 | 1 | 5 | 41290466, 38569854, 31879964, 31702021, 21433395 | 1 | Chronic mucocutaneous candidosis | 0.8147374964880533 | ||
| P09936 | UCHL1 | Ubiquitin carboxyl-terminal hydrolase isozyme L1 | Tier 1.5 | 0.741 | 1 | B_cargo | 14 | 93.62 | 0 | 0 | 1 | 2 | 30863411 | 1 | early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome | 0.8048623975346616 | ||
| P43007 | SLC1A4 | Neutral amino acid transporter A | Tier 1.5 | 0.741 | 1 | B_cargo | 1 | 80.56 | 1 | 0 | 1 | 6 | 36219068, 31989939, 27571928, 26811678, 19046328, 16139842 | 1 | spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome | 0.8025684205131692 | ||
| Q6NUK1 | SLC25A24 | Mitochondrial adenyl nucleotide antiporter SLC25A24 | Tier 1.5 | 0.74 | 1 | B_cargo | 3 | 81.31 | 0 | 0 | 1 | 1 | 41871245 | 1 | Fontaine progeroid syndrome | 0.7984507086824493 | ||
| P98155 | VLDLR | Very low-density lipoprotein receptor | Tier 1.5 | 0.737 | 1 | B_cargo | 27 | 75.69 | 1 | 0 | 1 | 1 | 19188685 | 1 | Dysequilibrium syndrome | 0.790164037509625 | ||
| P21397 | MAOA | Amine oxidase [flavin-containing] A | Tier 1.5 | 0.733 | 1 | B_cargo | 4 | 97.0 | 0 | 0 | 1 | 2 | 36795559, 26841904 | 1 | Brunner syndrome | 0.7777423430063588 | ||
| Q15813 | TBCE | Tubulin-specific chaperone E | Tier 1.5 | 0.732 | 1 | B_cargo | 6 | 89.19 | 1 | 0 | 1 | 1 | 34448574 | 1 | hypoparathyroidism-retardation-dysmorphism syndrome | 0.7744447925917005 | ||
| Q01105 | SET | Protein SET | Tier 1.5 | 0.73 | 1 | B_cargo | 3 | 77.62 | 0 | 0 | 1 | 556 | 42039565, 41993416, 41969971, 41928908, 41902675, 41898181, 41881226, 41770599, 41761637, 41666037, 41644952, 41542672, 41498743, 41486176, 41405351, 41226313, 41207276, 41169591, 41135899, 41099717, 41020397, 40892043, 40808600, 40710098, 40706113, 40656531, 40618375, 40598898, 40394224, 40362575, 40333723, 40313273, 40306472, 40270429, 40259434, 40245514, 40243681, 40220375, 40215752, 40212654, 40209705, 40083221, 39971069, 39959072, 39954262, 39939919, 39865031, 39832878, 39803439, 39744100, 30485711 | 1 | intellectual disability, autosomal dominant 58 | 0.7663060887583324 | ||
| P50461 | CSRP3 | Cysteine and glycine-rich protein 3 | Tier 1.5 | 0.728 | 1 | B_cargo | 2 | 73.44 | 0 | 0 | 1 | 1 | 29222138 | 1 | dilated cardiomyopathy 1M | 0.7615568697921314 | ||
| Q13043 | STK4 | Serine/threonine-protein kinase 4 | Tier 1.5 | 0.728 | 1 | B_cargo | 16 | 75.94 | 1 | 0 | 1 | 1 | 31707227 | 1 | combined immunodeficiency due to STK4 deficiency | 0.7613382040802787 | ||
| Q16719 | KYNU | Kynureninase | Tier 1.5 | 0.726 | 1 | B_cargo | 3 | 95.44 | 0 | 0 | 1 | 2 | 39045230 | 1 | vertebral, cardiac, renal, and limb defects syndrome 2 | 0.7538237163234831 | ||
| P07237 | P4HB | Protein disulfide-isomerase | Tier 1.5 | 0.723 | 1 | B_cargo | 14 | 88.5 | 1 | 0 | 1 | 2 | 31625090, 28952381 | 1 | Cole-Carpenter syndrome | 0.7447295842045853 | ||
| Q15796 | SMAD2 | SMAD family member 2 | Tier 1.5 | 0.72 | 1 | B_cargo | 10 | 77.62 | 0 | 0 | 1 | 7 | 37415558, 35356877, 33124760, 22899759, 21266541, 16775010, 11856769 | 1 | Loeys-Dietz syndrome 6 | 0.7333699386757103 | ||
| Q9NXG6 | P4HTM | Transmembrane prolyl 4-hydroxylase | Tier 1.5 | 0.717 | 1 | B_cargo | 1 | 81.06 | 0 | 0 | 1 | 1 | 28685750 | 1 | hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities | 0.7218110110850424 | ||
| Q13158 | FADD | FAS-associated death domain protein | Tier 1.5 | 0.708 | 1 | B_cargo | 18 | 72.12 | 1 | 0 | 1 | 3 | 36309655, 30594071, 26318819 | 1 | FADD-related immunodeficiency | 0.6932338529214827 | ||
| P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Tier 1.5 | 0.706 | 1 | B_cargo | 51 | 85.56 | 0 | 0 | 1 | 2 | 41290466, 20711698 | 1 | rheumatoid arthritis | 0.6871251698480906 | ||
| Q9H082 | RAB33B | Ras-related protein Rab-33B | Tier 1.5 | 0.702 | 1 | B_cargo | 2 | 80.62 | 0 | 0 | 1 | 3 | 34248841, 32838280, 29754498 | 1 | Smith-McCort dysplasia 2 | 0.6718069684124652 | ||
| P06401 | PGR | Progesterone receptor | Tier 1.5 | 0.701 | 1 | B_cargo | 20 | 56.16 | 0 | 0 | 1 | 11 | 31226842, 25461163, 41716468, 41535871, 41318995, 39719189, 39028987, 38802696, 38512151, 36001395, 30428522 | 1 | endometriosis | 0.669096724339783 | ||
| Q05655 | PRKCD | Protein kinase C delta type | Tier 1.5 | 0.7 | 1 | B_cargo | 2 | 80.69 | 0 | 0 | 1 | 2 | 29961347, 29754498 | 1 | autoimmune lymphoproliferative syndrome | 0.6669954888212556 | ||
| Q13423 | NNT | NAD(P) transhydrogenase, mitochondrial | Tier 1.5 | 0.692 | 1 | B_cargo | 3 | 90.88 | 0 | 0 | 1 | 3 | 40903908, 36413497, 18425911 | 1 | familial glucocorticoid deficiency | 0.638839481734631 | ||
| P35354 | PTGS2 | Prostaglandin G/H synthase 2 | Tier 1.5 | 0.69 | 1 | B_cargo | 7 | 93.0 | 0 | 0 | 1 | 7 | 39503504, 38959476, 33230429, 22544606, 19723884, 17909039, 31482734 | 1 | rheumatoid arthritis | 0.6335569514731725 | ||
| P17096 | HMGA1 | High mobility group protein HMG-I/HMG-Y | Tier 1.5 | 0.674 | 1 | B_cargo | 5 | 65.0 | 0 | 0 | 1 | 4 | 41871245, 31538905, 20961861, 19956671 | 1 | HIV infection | 0.5809402815127065 | ||
| Q01518 | CAP1 | Adenylyl cyclase-associated protein 1 | Tier 1.5 | 0.668 | 1 | B_cargo | 5 | 81.75 | 1 | 0 | 1 | 1 | 37614296 | 1 | neurodegenerative disease | 0.5608927359093832 | ||
| P57075 | UBASH3A | Ubiquitin-associated and SH3 domain-containing protein A | Tier 1.5 | 0.667 | 1 | B_cargo | 2 | 82.25 | 0 | 0 | 1 | 1 | 41680500 | 1 | rheumatoid arthritis | 0.5578057740717796 | ||
| P09668 | CTSH | Pro-cathepsin H | Tier 1.5 | 0.664 | 1 | B_cargo | 2 | 93.88 | 0 | 0 | 1 | 1 | 38811951 | 1 | type 1 diabetes mellitus | 0.5481319551898879 | ||
| Q7Z3B1 | NEGR1 | Neuronal growth regulator 1 | Tier 1.5 | 0.663 | 1 | B_cargo | 2 | 81.62 | 0 | 0 | 1 | 1 | 29754498 | 1 | intelligence | 0.544218102469465 | ||
| P12270 | TPR | Nucleoprotein TPR | Tier 1.5 | 0.663 | 1 | B_cargo | 4 | 60.5 | 0 | 0 | 1 | 1 | 33217386 | 1 | HIV infection | 0.5418451313960712 | ||
| Q96RS0 | TGS1 | Trimethylguanosine synthase | Tier 1.5 | 0.661 | 1 | B_cargo | 2 | 59.94 | 0 | 0 | 1 | 1 | 27572987 | 1 | neurodegenerative disease | 0.5358070245955443 | ||
| P37802 | TAGLN2 | Transgelin-2 | Tier 1.5 | 0.658 | 1 | B_cargo | 1 | 88.12 | 0 | 0 | 1 | 3 | 41358073, 32527800 | 1 | neurodegenerative disease | 0.5261379875719714 | ||
| Q13794 | PMAIP1 | Phorbol-12-myristate-13-acetate-induced protein 1 | Tier 1.5 | 0.658 | 1 | B_cargo | 1 | 81.94 | 0 | 0 | 1 | 1 | 21616931 | 1 | neurodegenerative disease | 0.527389679534353 | ||
| Q16798 | ME3 | NADP-dependent malic enzyme, mitochondrial | Tier 1.5 | 0.658 | 1 | B_cargo | 5 | 91.69 | 1 | 0 | 1 | 1 | 39602246 | 1 | open-angle glaucoma | 0.5259955902523525 | ||
| O15067 | PFAS | Phosphoribosylformylglycinamidine synthase | Tier 1.5 | 0.656 | 1 | B_cargo | 3 | 92.31 | 1 | 0 | 1 | 10 | 41934998, 41928580, 40936959, 40862935, 40772729, 40658928, 39110961, 38202993, 37051269, 34991260 | 1 | dyskeratosis congenita | 0.5199677146803817 | ||
| Q6FI81 | CIAPIN1 | Anamorsin | Tier 1.5 | 0.654 | 1 | B_cargo | 3 | 80.19 | 0 | 0 | 1 | 1 | 40506465 | 1 | neurodegenerative disease | 0.5125028552204193 | ||
| P32119 | PRDX2 | Peroxiredoxin-2 | Tier 1.5 | 0.654 | 1 | B_cargo | 7 | 97.75 | 0 | 0 | 1 | 2 | 41097770 | 1 | neurodegenerative disease | 0.5148660529122818 | ||
| Q7L7L0 | H2AC25 | Histone H2A type 3 | Tier 1.5 | 0.651 | 1 | B_cargo | 2 | 90.94 | 1 | 0 | 1 | 2 | 38045440, 37593997 | 1 | infectious disease | 0.5030392466541774 | ||
| O15021 | MAST4 | Microtubule-associated serine/threonine-protein kinase 4 | Tier 1.5 | 0.649 | 1 | B_cargo | 1 | 42.53 | 0 | 0 | 1 | 1 | 18376136 | 1 | Neurodevelopmental disorder | 0.4951959408492021 | ||
| P16455 | MGMT | Methylated-DNA--protein-cysteine methyltransferase | Tier 1.5 | 0.647 | 1 | B_cargo | 21 | 85.12 | 1 | 0 | 1 | 4 | 41951573, 38806504, 31601097, 28499389 | 1 | Abnormality of the skeletal system | 0.49129662019672776 | ||
| P84090 | ERH | Enhancer of rudimentary homolog | Tier 1.5 | 0.646 | 1 | B_cargo | 4 | 95.94 | 0 | 0 | 1 | 1 | 41785608 | 1 | neurodegenerative disease | 0.48655131342191105 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;